February 27, 2017 8:14 PM ET


Company Overview of Visterra, Inc.

Key Executives for Visterra, Inc.

NameBoard RelationshipsTitleAge
Brian J. G. Pereira M.D.20 RelationshipsChief Executive Officer, President and Director57
Alan L. Crane M.A., M.B.A.84 RelationshipsFounder, Chairman of The Board, Chairman of Compensation Committee and Member of Audit Committee53
Ram Sasisekharan Ph.D.48 RelationshipsFounder and Director51
David A. Arkowitz 5 RelationshipsChief Financial Officer and Chief Operating Officer55

Visterra, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Alan L. Crane M.A., M.B.A. 84 RelationshipsCerulean Pharma Inc.53
Brian J. G. Pereira M.D. 20 RelationshipsVisterra, Inc.57
Ram Sasisekharan Ph.D. 48 RelationshipsCerulean Pharma Inc.51
Edwin M. Kania Jr. 96 RelationshipsFlagship Pioneering58
Akshay K. Vaishnaw M.D., Ph.D. 35 RelationshipsAlnylam Pharmaceuticals, Inc.53
View All Board Members

Visterra, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jr.Edwin M. Kania96 Relationships3 Executives
Compensation Committee M.A., M.B.A.Alan L. Crane84 Relationships4 Executives
Nominating Committee M.D., Ph.D.Akshay K. Vaishnaw35 Relationships2 Executives
Corporate Governance Committee M.D., Ph.D.Akshay K. Vaishnaw35 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$516.0K
Compensation as of Fiscal Year 2016
Visterra, Inc. CEO Compensation
Industry Average


CTI BioPharma Corp. Announces Executive Changes, with Effect from March 20, 2017
February 27, 2017 6:30 AM ET
Rigel Pharmaceuticals, Inc. Announces Board Changes
February 24, 2017 10:24 PM ET
Sangamo Therapeutics, Inc. Announces Termination of Dale Ando as Chief Medical Officer
February 24, 2017 10:10 PM ET
Ian Smith Notifies Ophthotech Corporation Request Not to Be Nominates for Re-Election to the Board of Directors
February 24, 2017 9:14 PM ET
Santhera Pharmaceuticals Opens of U.S. Office in Burlington, MA; Appoints Todd Bazemore to Lead U.S. Operations in Burlington, MA
February 24, 2017 1:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Visterra, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.